中國織材控股(03778.HK)年度收入約11.070億元 同比減少約22.8%
格隆匯3月26日丨中國織材控股(03778.HK)發佈公吿,截至2023年12月31日止年度,公司收入約人民幣11.070億元,較去年減少約人民幣3.011億元或22.8%。年度收入減少,主要是由於紗線產品銷量和平均售價減少所致。由於市場狀況欠佳,因此,銷量由上年度約103,479噸減少約6.9%至該年度約96,330噸。集團紗線產品的整體平均售價由上年度每噸約人民幣12,738元減少17.1%至該年度每噸約人民幣10,558元。公司擁有人應占虧損約人民幣2,650萬元,而上年度則約為人民幣1,260萬元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.